Alcon Revenue 2019-2023 | ALC
Alcon annual/quarterly revenue history and growth rate from 2019 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Alcon revenue for the quarter ending December 31, 2023 was $2.352B, a 8.34% increase year-over-year.
- Alcon revenue for the twelve months ending December 31, 2023 was $9.455B, a 8.47% increase year-over-year.
- Alcon annual revenue for 2023 was $9.455B, a 8.47% increase from 2022.
- Alcon annual revenue for 2022 was $8.717B, a 5.14% increase from 2021.
- Alcon annual revenue for 2021 was $8.291B, a 21.34% increase from 2020.
| Alcon Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $9,455 |
| 2022 | $8,717 |
| 2021 | $8,291 |
| 2020 | $6,833 |
| 2019 | $7,508 |
| 2018 | $7,153 |
| Alcon Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $2,352 |
| 2023-09-30 | $2,329 |
| 2023-06-30 | $2,422 |
| 2023-03-31 | $2,352 |
| 2022-12-31 | $2,171 |
| 2022-09-30 | $2,140 |
| 2022-06-30 | $2,217 |
| 2022-03-31 | $2,189 |
| 2021-12-31 | $2,149 |
| 2021-09-30 | $2,102 |
| 2021-06-30 | $2,110 |
| 2021-03-31 | $1,930 |
| 2020-12-31 | $1,940 |
| 2020-09-30 | $1,838 |
| 2020-06-30 | $1,214 |
| 2020-03-31 | $1,841 |
| 2019-12-31 | $1,913 |
| 2019-09-30 | $1,868 |
| 2019-06-30 | $1,903 |
| 2019-03-31 | $1,824 |
| 2018-12-31 | |
| 2018-09-30 | $1,762 |
| 2018-06-30 | $1,820 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $39.621B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.968B | 26.53 |
| Intuitive Surgical (ISRG) | United States | $134.917B | 81.28 |
| Edwards Lifesciences (EW) | United States | $51.275B | 33.37 |
| DexCom (DXCM) | United States | $50.673B | 76.76 |
| IQVIA Holdings (IQV) | United States | $41.520B | 24.09 |
| IDEXX Laboratories (IDXX) | United States | $40.226B | 47.15 |
| STERIS (STE) | Ireland | $20.760B | 24.26 |
| Waters (WAT) | United States | $19.208B | 28.23 |
| Hologic (HOLX) | United States | $17.704B | 19.81 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.503B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.413B | 77.25 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.136B | 14.16 |
| Sysmex ADR (SSMXY) | Japan | $10.805B | 33.88 |
| Teleflex (TFX) | United States | $9.442B | 14.70 |
| Globus Medical (GMED) | United States | $8.357B | 24.50 |
| Penumbra (PEN) | United States | $7.873B | 89.47 |
| Masimo (MASI) | United States | $6.371B | 36.70 |
| Glaukos (GKOS) | United States | $5.385B | 0.00 |
| TransMedics (TMDX) | United States | $4.190B | 397.56 |
| Integer Holdings (ITGR) | United States | $3.791B | 22.90 |
| LivaNova (LIVN) | United Kingdom | $3.380B | 20.07 |
| PROCEPT BioRobotics (PRCT) | United States | $3.104B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.779B | 19.07 |
| Tandem Diabetes Care (TNDM) | United States | $2.722B | 0.00 |
| Inari Medical (NARI) | United States | $2.431B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.421B | 20.48 |
| RxSight (RXST) | United States | $2.244B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.963B | 8.56 |
| Veracyte (VCYT) | United States | $1.538B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.483B | 0.00 |
| Artivion (AORT) | United States | $0.972B | 93.20 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.898B | 17.46 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.791B | 0.00 |
| Paragon 28 (FNA) | United States | $0.788B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.759B | 0.00 |
| SiBone (SIBN) | United States | $0.618B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.611B | 20.73 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.557B | 0.00 |
| IRadimed (IRMD) | United States | $0.550B | 30.79 |
| Pacific Biosciences Of California (PACB) | United States | $0.458B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.381B | 0.00 |
| Nevro (NVRO) | United States | $0.373B | 0.00 |
| NeuroPace (NPCE) | United States | $0.362B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.329B | 11.26 |
| Sight Sciences (SGHT) | United States | $0.276B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.259B | 0.00 |
| AxoGen (AXGN) | United States | $0.257B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.236B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.211B | 0.00 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| Inogen (INGN) | United States | $0.194B | 0.00 |
| CVRx (CVRX) | United States | $0.168B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.168B | 0.00 |
| Accuray (ARAY) | United States | $0.166B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.164B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.153B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.148B | 7.54 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.092B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.085B | 0.00 |
| Neuronetics (STIM) | United States | $0.076B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Envoy Medical (COCH) | United States | $0.064B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 127.67 |
| Monogram Orthopaedics (MGRM) | United States | $0.060B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.058B | 0.00 |
| InspireMD (NSPR) | Israel | $0.049B | 0.00 |
| DarioHealth (DRIO) | United States | $0.048B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
| LENSAR (LNSR) | United States | $0.039B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |